Covered recipient · General Payments record
GITANJALI B BAVEJA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,558.87
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $969.84 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $444.43 | 16 |
| BIOTISSUE HOLDINGS INC. | $253.96 | 4 |
| Janssen Global Services, LLC | $95.79 | 1 |
| Dompe US, Inc. | $33.67 | 1 |
| GLAUKOS CORPORATION | $26.21 | 1 |
| Harrow Eye, LLC | $25.39 | 1 |
| Bausch & Lomb Americas Inc. | $24.09 | 1 |
| RxSight Inc | $22.59 | 1 |
| Oyster Point Pharma, Inc. | $22.57 | 1 |
| Amgen Inc. | $21.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.39 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293045 | CMS |
| ABBVIE INC. | $33.04 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293047 | CMS |
| ABBVIE INC. | $19.22 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293049 | CMS |
| ABBVIE INC. | $29.15 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293051 | CMS |
| ABBVIE INC. | $33.05 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293053 | CMS |
| ABBVIE INC. | $22.42 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293055 | CMS |
| ABBVIE INC. | $29.16 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293057 | CMS |
| ABBVIE INC. | $32.57 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293059 | CMS |
| ABBVIE INC. | $33.86 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293061 | CMS |
| ABBVIE INC. | $28.19 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293063 | CMS |
| ABBVIE INC. | $27.28 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293065 | CMS |
| ABBVIE INC. | $27.30 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293067 | CMS |
| ABBVIE INC. | $26.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293069 | CMS |
| ABBVIE INC. | $29.27 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293071 | CMS |
| ABBVIE INC. | $27.66 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293073 | CMS |
| ABBVIE INC. | $26.31 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293075 | CMS |
| Amgen Inc. | $21.14 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111526270 | CMS |
| Bausch & Lomb Americas Inc. | $24.09 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140348508 | CMS |
| BIOTISSUE HOLDINGS INC. | $21.50 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148779507 | CMS |
| BIOTISSUE HOLDINGS INC. | $18.76 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148776737 | CMS |
| BIOTISSUE HOLDINGS INC. | $4.61 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148773584 | CMS |
| BIOTISSUE HOLDINGS INC. | $209.09 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148772406 | CMS |
| Dompe US, Inc. | $33.67 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151403612 | CMS |
| Glaukos Corporation | $26.21 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151987916 | CMS |
| Harrow Eye, LLC | $25.39 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145597980 | CMS |
| Janssen Global Services, LLC | $95.79 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077590725 | CMS |
| Oyster Point Pharma, Inc. | $22.57 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147423953 | CMS |
| RxSight Inc | $22.59 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144212776 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.